INmune Bio(INMB) - 2023 Q2 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants David Moss - Chief Financial Officer RJ Tesi - Chief Executive Officer & Chief Medical Officer Conference Call Participants Joel Beatty - Baird Operator Greetings, and welcome to the INmune Bio Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure ...